Immune Design Corp.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Immune Design Corp.'s past years’ income statements indicate that its last revenue has decreased compared to the previous period by 69% to $2,196,000. Profit margin reached -2494%. Total operating expenses were $59,246,000.

Profit Margin

Immune Design Corp. (NASDAQ:IMDZ): Profit margin
2014 6.43M -34.15M -530.87%
2015 9.51M -39.44M -414.77%
2016 13.26M -53.53M -403.7%
2017 7.19M -51.86M -720.81%
2018 2.19M -54.75M -2493.53%

IMDZ Income Statement (2014 – 2018)

2018 2017 2016 2015 2014
Revenue
Revenue
2.19M7.19M13.26M9.51M6.43M
Cost of revenue
1.43M84K481K774K638K
Gross profit
761K7.11M12.77M8.73M5.79M
Operating exp.
Research and development
42.41M43.67M45.13M33.08M22.74M
Selling and marketing
00000
Total operating expenses
59.24M60.00M67.47M48.99M36.31M
Operating income
-57.05M-52.81M-54.21M-39.48M-29.87M
Other income (expenses), net
2.29M950K684K40K-4.27M
Income before tax
-54.75M-51.86M-53.53M-39.44M-34.15M
Income tax expense
2.29M950K684K40K-4.27M
Net income
-54.75M-51.86M-53.53M-39.44M-34.15M
Earnings per share
Basic EPS
-1.14-1.08-1.11-0.82-0.71
Diluted EPS
-1.14-1.75-2.47-2.06-4.56
Data sourceData sourceData sourceData sourceData source